367 related articles for article (PubMed ID: 9607727)
1. Partial androgen insensitivity and correlations with the predicted three dimensional structure of the androgen receptor ligand-binding domain.
Yong EL; Tut TG; Ghadessy FJ; Prins G; Ratnam SS
Mol Cell Endocrinol; 1998 Feb; 137(1):41-50. PubMed ID: 9607727
[TBL] [Abstract][Full Text] [Related]
2. Androgen receptor mutations causing human androgen insensitivity syndromes show a key role of residue M807 in Helix 8-Helix 10 interactions and in receptor ligand-binding domain stability.
Ong YC; Kolatkar PR; Yong EL
Mol Hum Reprod; 2002 Feb; 8(2):101-8. PubMed ID: 11818512
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis of androgen insensitivity.
Brinkmann AO
Mol Cell Endocrinol; 2001 Jun; 179(1-2):105-9. PubMed ID: 11420135
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the molecular consequences of different mutations at residue 754 and 690 of the androgen receptor (AR) and androgen insensitivity syndrome (AIS) phenotype.
Tadokoro R; Bunch T; Schwabe JW; Hughes IA; Murphy JC
Clin Endocrinol (Oxf); 2009 Aug; 71(2):253-60. PubMed ID: 19178528
[TBL] [Abstract][Full Text] [Related]
5. Partial androgen insensitivity with phenotypic variation caused by androgen receptor mutations that disrupt activation function 2 and the NH(2)- and carboxyl-terminal interaction.
Quigley CA; Tan JA; He B; Zhou ZX; Mebarki F; Morel Y; Forest MG; Chatelain P; Ritzén EM; French FS; Wilson EM
Mech Ageing Dev; 2004; 125(10-11):683-95. PubMed ID: 15541764
[TBL] [Abstract][Full Text] [Related]
6. An examination of how different mutations at arginine 855 of the androgen receptor result in different androgen insensitivity phenotypes.
Elhaji YA; Wu JH; Gottlieb B; Beitel LK; Alvarado C; Batist G; Trifiro MA
Mol Endocrinol; 2004 Aug; 18(8):1876-86. PubMed ID: 15118070
[TBL] [Abstract][Full Text] [Related]
7. Disrupted amino- and carboxyl-terminal interactions of the androgen receptor are linked to androgen insensitivity.
Thompson J; Saatcioglu F; Jänne OA; Palvimo JJ
Mol Endocrinol; 2001 Jun; 15(6):923-35. PubMed ID: 11376111
[TBL] [Abstract][Full Text] [Related]
8. Two de novo mutations in the AR gene cause the complete androgen insensitivity syndrome in a pair of monozygotic twins.
Mongan NP; Jääskeläinen J; Green K; Schwabe JW; Shimura N; Dattani M; Hughes IA
J Clin Endocrinol Metab; 2002 Mar; 87(3):1057-61. PubMed ID: 11889162
[TBL] [Abstract][Full Text] [Related]
9. Impaired nuclear translocation, nuclear matrix targeting, and intranuclear mobility of mutant androgen receptors carrying amino acid substitutions in the deoxyribonucleic acid-binding domain derived from androgen insensitivity syndrome patients.
Kawate H; Wu Y; Ohnaka K; Tao RH; Nakamura K; Okabe T; Yanase T; Nawata H; Takayanagi R
J Clin Endocrinol Metab; 2005 Nov; 90(11):6162-9. PubMed ID: 16118342
[TBL] [Abstract][Full Text] [Related]
10. Discordant measures of androgen-binding kinetics in two mutant androgen receptors causing mild or partial androgen insensitivity, respectively.
Shkolny DL; Beitel LK; Ginsberg J; Pekeles G; Arbour L; Pinsky L; Trifiro MA
J Clin Endocrinol Metab; 1999 Feb; 84(2):805-10. PubMed ID: 10022458
[TBL] [Abstract][Full Text] [Related]
11. Novel amino acid substitutional mutation, tyrosine-739-aspartic acid, in the androgen receptor gene in complete androgen insensitivity syndrome.
Suzuki K; Fukabori Y; Nakazato H; Hasumi M; Matsui H; Ito K; Kurokawa K; Yamanaka H
Int J Androl; 2001 Jun; 24(3):183-8. PubMed ID: 11380707
[TBL] [Abstract][Full Text] [Related]
12. An androgen receptor mutation in the direct vicinity of the proposed C-terminal alpha-helix of the ligand binding domain containing the AF-2 transcriptional activating function core is associated with complete androgen insensitivity.
Peters I; Weidemann W; Romalo G; Knorr D; Schweikert HU; Spindler KD
Mol Cell Endocrinol; 1999 Feb; 148(1-2):47-53. PubMed ID: 10221770
[TBL] [Abstract][Full Text] [Related]
13. Impaired helix 12 dynamics due to proline 892 substitutions in the androgen receptor are associated with complete androgen insensitivity.
Elhaji YA; Stoica I; Dennis S; Purisima EO; Lumbroso R; Beitel LK; Trifiro MA
Hum Mol Genet; 2006 Mar; 15(6):921-31. PubMed ID: 16449235
[TBL] [Abstract][Full Text] [Related]
14. The use of androgen receptor amino/carboxyl-terminal interaction assays to investigate androgen receptor gene mutations in subjects with varying degrees of androgen insensitivity.
Ghali SA; Gottlieb B; Lumbroso R; Beitel LK; Elhaji Y; Wu J; Pinsky L; Trifiro MA
J Clin Endocrinol Metab; 2003 May; 88(5):2185-93. PubMed ID: 12727974
[TBL] [Abstract][Full Text] [Related]
15. A new mutation of the androgen receptor, P817A, causing partial androgen insensitivity syndrome: in vitro and structural analysis.
Lumbroso S; Wagschal A; Bourguet W; Georget V; Mazen I; Servant N; Audran F; Sultan C; Auzou G
J Mol Endocrinol; 2004 Jun; 32(3):679-87. PubMed ID: 15171708
[TBL] [Abstract][Full Text] [Related]
16. A novel mutation in the human androgen receptor suggests a regulatory role for the hinge region in amino-terminal and carboxy-terminal interactions.
Deeb A; Jääskeläinen J; Dattani M; Whitaker HC; Costigan C; Hughes IA
J Clin Endocrinol Metab; 2008 Oct; 93(10):3691-6. PubMed ID: 18697867
[TBL] [Abstract][Full Text] [Related]
17. G708E mutation in the androgen receptor results in complete loss of androgen function.
Rajender S; Pooja S; Gupta NJ; Chakrabarty B; Singh L; Thangaraj K
J Androl; 2011; 32(2):193-8. PubMed ID: 20671138
[TBL] [Abstract][Full Text] [Related]
18. Human androgen receptor gene ligand-binding-domain mutations leading to disrupted interaction between the N- and C-terminal domains.
Jääskeläinen J; Deeb A; Schwabe JW; Mongan NP; Martin H; Hughes IA
J Mol Endocrinol; 2006 Apr; 36(2):361-8. PubMed ID: 16595706
[TBL] [Abstract][Full Text] [Related]
19. Clinical and biochemical investigations and molecular analysis of subjects with mutations in the androgen receptor gene.
Weidemann W; Linck B; Haupt H; Mentrup B; Romalo G; Stockklauser K; Brinkmann AO; Schweikert HU; Spindler KD
Clin Endocrinol (Oxf); 1996 Dec; 45(6):733-9. PubMed ID: 9039340
[TBL] [Abstract][Full Text] [Related]
20. Human androgen insensitivity due to point mutations encoding amino acid substitutions in the androgen receptor steroid-binding domain.
Murono K; Mendonca BB; Arnhold IJ; Rigon AC; Migeon CJ; Brown TR
Hum Mutat; 1995; 6(2):152-62. PubMed ID: 7581399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
